Clear Harbor Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$799K Buy
18,726
+13,538
+261% +$735K 0.05% 244
2026
Q1
$326K Buy
5,188
+1,638
+46% +$131K 0.02% 355
2025
Q4
$338K Buy
3,550
+741
+26% +$72.6K 0.02% 346
2025
Q3
$274K Hold
2,809
0.02% 366
2025
Q2
$302K Hold
2,809
0.02% 338
2025
Q1
$283K Hold
2,809
0.02% 330
2024
Q4
$251K Buy
+2,809
New +$247K 0.02% 332
2024
Q2
Sell
-3,677
Closed -$252K 371
2024
Q1
$252K Buy
+3,677
New +$236K 0.02% 313
2020
Q4
Sell
-550
Closed -$21K 372
2020
Q3
$21K Buy
+550
New +$21.2K ﹤0.01% 497
2020
Q1
Sell
-550
Closed -$24.9K 335
2019
Q4
$24.9K Buy
+550
New +$23K ﹤0.01% 494

Other funds holding BSX

Clear Harbor Asset Management's BSX Position: Q2 2026 in Review

Clear Harbor Asset Management increased its Boston Scientific (BSX) stake by 261% in Q2 2026, buying an estimated $735K and bringing the position to 18,726 shares worth $799K. The position accounts for 0.05% of the portfolio, ranked #244.

Clear Harbor Asset Management first reported a position in BSX in Q4 2019 and has held it in 10 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clear Harbor Asset Management held 18,726 shares of Boston Scientific worth $799K as of Q2 2026.
  • Clear Harbor Asset Management bought 13,538 Boston Scientific shares in Q2 2026, an estimated $735K.
  • Boston Scientific made up 0.05% of Clear Harbor Asset Management's portfolio in Q2 2026, its #244 holding.
  • Clear Harbor Asset Management first reported a position in Boston Scientific in Q4 2019 and has held it in 10 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.